TXG
10x Genomics, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom +5.2% ·
netto nieuwe posities +5.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 153.99K | $11.76M | n/a | n/a |
| Q2 2026 | 113 | +6 | 98.93M | $3.79B | +15 | −8 |
| Q1 2026 | 109 | +3 | 94.02M | $1.99B | +12 | −10 |
| Q4 2025 | 107 | +3 | 97.86M | $1.59B | +4 | n/a |
| Q3 2025 | 19 | -2 | 71.88M | $839.83M | n/a | −3 |
| Q2 2025 | 19 | +1 | 64.66M | $748.72M | +2 | −1 |
| Q1 2025 | 15 | 0 | 30.56M | $266.82M | +1 | −1 |
| Q4 2024 | 15 | +1 | 24.83M | $356.61M | +3 | −2 |
| Q3 2024 | 13 | 0 | 22.71M | $512.82M | +1 | −1 |
| Q2 2024 | 13 | n/a | 21.07M | $409.76M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 13.89M | +8.2% | $160.87M | 1.2% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 12.44M | n/a | $144.06M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passief) | 9.43M | n/a | $109.25M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 4 | Fidelity (FMR) ✦ | 9.00M | n/a | $104.18M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 5 | AQR Capital Management ✦ | 4.14M | +241.3% | $47.92M | 0.0% | ▲ Add | 5 | SEC ↗ ×6 |
| 6 | Millennium Management ✦ | 2.88M | -46.4% | $33.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 2.65M | +41.2% | $30.70M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | State Street Global Advisors ✦ (passief) | 2.49M | +37.5% | $28.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.89M | Nieuw | $21.90M | 0.0% | New | 1 | SEC ↗ ×4 |
| 10 | Renaissance Technologies ✦ | 1.47M | +113.5% | $17.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Capital World Investors ✦ | 1.45M | 0.0% | $16.82M | 0.0% | Held | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.03M | -28.0% | $11.88M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 746.27K | -62.4% | $8.64M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 14 | Marshall Wace ✦ | 399.70K | -4.2% | $4.63M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 15 | T. Rowe Price ✦ | 271.08K | +7.9% | $3.14M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 16 | Citadel Advisors ✦ | 195.94K | -81.6% | $2.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 123.60K | +645.5% | $1.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 76.54K | Nieuw | $886,310 | 0.0% | New | 1 | SEC ↗ |
| 19 | Norges Bank ✦ (passief) | 72.67K | -33.1% | $841,565 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Wellington Management | $21.90M | 0.0% |
| Gotham Asset Management | $886,310 | 0.0% |
Verlaten
| PRIMECAP Management | $261,900 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 328 houders, 124.40M aandelen, $2.59B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 1.00K aand · $78,228
Director · 1.22K aand · $100,542
Director · 2.27K aand · $185,391
Director · 1.32K aand · $107,082
Director · 614 aand · $48,820
Director · 292 aand · $22,833
Officer, Director · 2.80K aand · $230,622
Officer, Director · 9.90K aand · $810,071
Officer, Director · 9.30K aand · $752,401
Officer, Director · 2.00K aand · $159,239
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie